HR (95% CI) | |||
---|---|---|---|
Crude | Partially adjusted a | Fully adjusted b | |
Combination of CP (IgA) and history of diabetes | |||
CP (IgA) neg. and diabetes neg. | 1ref | 1ref | 1ref |
CP (IgA) neg. and diabetes pos. | 2.41 (1.21–4.80) | 2.31 (1.16–4.61) | 2.16 (1.08–4.33) |
CP (IgA) pos. and diabetes neg. | 1.64 (0.92–2.90) | 1.63 (0.93–2.90) | 1.60 (0.89–2.87) |
CP (IgA) pos. and diabetes pos. | 3.20 (1.61–6.38) | 3.04 (1.51–6.12) | 2.63 (1.29–5.36) |
Combination of CP (IgG) and history of diabetes | |||
CP (IgG) neg. and diabetes neg. | 1ref | 1ref | 1ref |
CP (IgG) neg. and diabetes pos. | 2.21 (1.11–4.40) | 2.10 (1.05–4.20) | 1.88 (0.93–3.78) |
CP (IgG) pos. and diabetes neg. | 1.43 (0.81–2.53) | 1.41 (0.79–2.50) | 1.35 (0.76–2.41) |
CP (IgG) pos. and diabetes pos. | 3.21 (1.61–6.39) | 3.07 (1.53–6.13) | 2.77 (1.36–5.64) |
Combination of ch-hsp60 and history of diabetes | |||
Ch-hsp60 neg. and diabetes neg. | 1ref | 1ref | 1ref |
Ch-hsp60 neg. and diabetes pos. | 2.14 (1.22–3.78) | 2.05 (1.15–3.63) | 1.78 (1.01–3.18) |
Ch-hsp60 pos. and diabetes neg. | 1.06 (0.54–2.08) | 1.04 (0.53–2.04) | 0.93 (0.47–1.84) |
Ch-hsp60 pos. and diabetes pos. | 2.82 (1.19–6.68) | 2.66 (1.12–6.35) | 2.55 (1.06–6.17) |